Novel therapies for hemodialysis vascular access dysfunction: Myth or reality?

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 12, 2013, Pages 2202-2212

  Terry, Christi M ^a   Dember, Laura M ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; ELASTASE; NATRIURETIC PEPTIDE TYPE C; PACLITAXEL; PIOGLITAZONE; PLACEBO; RAPAMYCIN; ROSIGLITAZONE;

ANASTOMOSIS STENOSIS; ARTERIOVENOUS FISTULA; ARTICLE; BRACHYTHERAPY; CELL TRANSPLANTATION; CRYOTHERAPY; ELECTROMAGNETIC RADIATION; EXTERNAL JUGULAR VEIN; GENE EXPRESSION; GENE TARGETING; HEMODIALYSIS; HEMODYNAMICS; HUMAN; IATROGENIC DISEASE; IMMUNOGENICITY; NITINOL STENT; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); TISSUE TRANSPLANTATION; UREMIA; VASCULAR ACCESS DYSFUNCTION; ANIMAL; ANIMAL MODEL; ARTERIOVENOUS SHUNT; BLOOD FLOW; BLOOD VESSEL TRANSPLANTATION; ENDOVASCULAR SURGERY; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; NEOINTIMA; PATHOLOGY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REOPERATION; RISK FACTOR; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SYSTEM INJURIES;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; ENDOVASCULAR PROCEDURES; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERPLASIA; MODELS, ANIMAL; NEOINTIMA; REGIONAL BLOOD FLOW; RENAL DIALYSIS; REOPERATION; RISK FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SYSTEM INJURIES;

EID: 84889826322     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07360713     Document Type: Article

References (96)

1. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR Jr., Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI; DAC Study Group: Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 360: 2191-2201, 2009
2. Lok CE, Moist L, Hemmelgarn BR, Tonelli M, Vazquez MA, Dorval M, Oliver M, Donnelly S, Allon M, Stanley K; Fish Oil Inhibition of Stenosis inHemodialysisGrafts (FISH) StudyGroup: Effect of fish oil supplementation on graft patency and cardiovascular events among patients with newsynthetic arteriovenous hemodialysis grafts: A randomized controlled trial. JAMA 307: 1809-1816, 2012
3. Lee T: Novel paradigms for dialysis vascular access: Downstream vascular biology-is there a final common pathway? Clin J Am Soc Nephrol 8: 2194-2201, 2013
4. Remuzzi A, Ene-Iordache B: Novel paradigms for dialysis vascular access: Upstream hemodynamics and vascular remodeling in dialysis access stenosis. Clin J Am Soc Nephrol 8: 2186-2193, 2013
5. Castier Y, Lehoux S, Hu Y, Foteinos G, Tedgui A, Xu Q: Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int 70: 315-320, 2006
6. Wong CY, de Vries MR, Wang Y, van der Vorst JR, Vahrmeijer AL, van Zonneveld AJ, Roy-Chaudhury P, Rabelink TJ, Quax PH, Rotmans JI: Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure [published online ahead of print May 15, 2013]. J Vasc Surg, 10.1016/j. jvs.2013.02.242
7. Abeles D, Kwei S, Stavrakis G, Zhang Y, Wang ET, García-Cardeña G: Gene expression changes evoked in a venous segment exposed to arterial flow. J Vasc Surg 44: 863-870, 2006
8. Kang L, Yamada S, Hernandez MC, Croatt AJ, Grande JP, Juncos JP, Vercellotti GM, Hebbel RP, Katusic ZS, Terzic A, Nath KA: Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula. Am J Physiol Renal Physiol 301: F845-F851, 2011
9. Kang L, Grande JP, Farrugia G, Croatt AJ, Katusic ZS, Nath KA: Functioning of an arteriovenous fistula requires heme oxygenase-2. Am J Physiol Renal Physiol 305: F545-F552, 2013
10. Sanders WG, Morisseau C, Hammock BD, Cheung AK, Terry CM: Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor. Am J Physiol Cell Physiol 303: C278-C290, 2012
11. Juncos JP, Tracz MJ, Croatt AJ, Grande JP, Ackerman AW, Katusic ZS, Nath KA: Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 74: 47-51, 2008
12. Kokubo T, Ishikawa N, Uchida H, Chasnoff SE, Xie X, Mathew S, Hruska KA, Choi ET: CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol 20: 1236-1245, 2009
13. Liang A, Wang Y, Han G, Truong L, Cheng J: Chronic kidney disease accelerates endothelial barrier dysfunction in a mouse model of an arteriovenous fistula. Am J Physiol Renal Physiol 304: F1413-F1420, 2013
14. Croatt AJ, Grande JP, Hernandez MC, Ackerman AW, Katusic ZS, Nath KA: Characterization of a model of an arteriovenous fistula in the rat: The effect of L-NAME. Am J Pathol 176: 2530-2541, 2010
15. Globerman AS, Chaouat M, Shlomai Z, Galun E, Zeira E, Zamir G: Efficient transgene expression from naked DNA delivered into an arterio-venous fistula model for kidney dialysis. J Gene Med 13: 611-621, 2011
16. Lin T, Horsfield C, Robson MG: Arteriovenous fistula in the rat tail: A new model of hemodialysis access dysfunction. Kidney Int 74: 528-531, 2008
17. Masaki T, Rathi R, Zentner G, Leypoldt JK, Mohammad SF, Burns GL, Li L, Zhuplatov S, Chirananthavat T, Kim SJ, Kern S, Holman J, Kim SW, Cheung AK: Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int 66: 2061-2069, 2004
18. Kelly BS, Narayana A, Heffelfinger SC, Denman D, Miller MA, Elson H, Armstrong J, Karle W, Nanayakkara N, Roy-Chaudhury P: External beam radiation attenuates venous neointimal hyperplasia in a pig model of arteriovenous polytetrafluoroethylene (PTFE) graft stenosis. Int J Radiat Oncol Biol Phys 54: 263-269, 2002
19. Terry CM, Kim SE, Li L, Goodrich KC, Hadley JR, Blumenthal DK, Parker DL, Cheung AK: Longitudinal assessment of hyperplasia using magnetic resonance imaging without contrast in a porcine arteriovenous graft model. Acad Radiol 16: 96-107, 2009
20. Li L, Terry CM, Blumenthal DK, Kuji T, Masaki T, Kwan BC, Zhuplatov I, Leypoldt JK, Cheung AK: Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 22: 3139-3146, 2007
21. Kuji T, Masaki T, Li L, Cheung AK: Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft model. Nephrol Dial Transplant 22: 2469-2475, 2007
22. Rotmans JI, Verhagen HJ, Velema E, de Kleijn DP, van den Heuvel M, Kastelein JJ, Pasterkamp G, Stroes ES: Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts. Kidney Int 65: 1897-1905, 2004
23. Rotmans JI, Velema E, Verhagen HJ, Blankensteijn JD, Kastelein JJ, de Kleijn DP, Yo M, Pasterkamp G, Stroes ES: Rapid, arteriovenous graft failure due to intimal hyperplasia: A porcine, bilateral, carotid arteriovenous graft model. J Surg Res 113: 161-171, 2003
24. Misra S, Gordon JD, Fu AA, Glockner JF, Chade AR, Mandrekar J, Lerman L, Mukhopadhyay D: The porcine remnant kidney model of chronic renal insufficiency. J Surg Res 135: 370-379, 2006
25. Misra S, Fu AA, Puggioni A, Glockner JF, Rajan DK, McKusick MA, Bjarnason H, Mukhopadhyay D: Increased expression of hypoxia-inducible factor-1 alpha in venous stenosis of arteriovenous polytetrafluoroethylene grafts in a chronic renal insufficiency porcine model. J Vasc Interv Radiol 19: 260-265, 2008
26. Misra S, Misra KD, Glockner JF: Vascular endothelial growth factor-A, matrixmetalloproteinase-1, and macrophagemigration inhibition factor changes in the porcine remnant kidney model: Evaluation by magnetic resonance imaging. J Vasc Interv Radiol 21: 1071-1077, 2010
27. Kraiss LW, Geary RL, Mattsson EJ, Vergel S, Au YP, Clowes AW: Acute reductions in blood flow and shear stress induce plateletderived growth factor-A expression in baboon prosthetic grafts. Circ Res 79: 45-53, 1996
28. Lundell A, Kelly AB, Anderson J, Marijianowski M, Rade JJ, Hanson SR, Harker LA: Reduction in vascular lesion formation by hirudin secreted from retrovirus-transduced confluent endothelial cells on vascular grafts in baboons. Circulation 100: 2018-2024, 1999
29. Prichard HL, Manson RJ, DiBernardo L, Niklason LE, Lawson JH, Dahl SL: An early study on the mechanisms that allow tissueengineered vascular grafts to resist intimal hyperplasia. J Cardiovasc Transl Res 4: 674-682, 2011
30. Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access.AmJ KidneyDis 48[Suppl 1]: S176-S247, 2006
31. Lumsden AB, MacDonald MJ, Kikeri D, Cotsonis GA, Harker LA, Martin LG: Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: Results of a prospective randomized study. J Vasc Surg 26: 382-390, 1997
32. Ram SJ, Work J, Caldito GC, Eason JM, Pervez A, Paulson WD: A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int 64: 272-280, 2003
33. Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW, DeYoung WJ, Blythe L, Stitt LW, Lindsay RM: Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 14: 2645-2653, 2003
34. Dember LM, Holmberg EF, Kaufman JS: Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney Int 66: 390-398, 2004
35. Robbin ML, Oser RF, Lee JY, Heudebert GR, Mennemeyer ST, Allon M: Randomized comparison of ultrasound surveillance and clinicalmonitoring on arteriovenous graft outcomes. Kidney Int 69: 730-735, 2006
36. Work J: Role of access surveillance and preemptive intervention. Semin Vasc Surg 24: 137-142, 2011
37. Waksman R, Pakala R: Drug-eluting balloon: The comeback kid? Circ Cardiovasc Interv 2: 352-358, 2009
38. Indermuehle A, Bahl R, Lansky AJ, Froehlich GM, Knapp G, Timmis A, Meier P: Drug-eluting balloon angioplasty for in-stent restenosis: A systematic reviewand meta-analysis of randomized controlled trials. Heart 99: 327-333, 2013
39. Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D: Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther 19: 263-272, 2012
40. Quinn SF, Schuman ES, Demlow TA, Standage BA, Ragsdale JW, Green GS, Sheley RC: Percutaneous transluminal angioplasty versus endovascular stent placement in the treatment of venous stenoses in patients undergoing hemodialysis: Intermediate results. J Vasc Interv Radiol 6: 851-855, 1995
41. Beathard GA: Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts. Kidney Int 43: 872-877, 1993
42. Hoffer EK, Sultan S, Herskowitz MM, Daniels ID, Sclafani SJ: Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. J Vasc Interv Radiol 8: 965-973, 1997
43. Kakisis JD, Avgerinos E, Giannakopoulos T, Moulakakis K, Papapetrou A, Liapis CD: Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy. J Vasc Surg 55: 472-478, 2012
44. Vogel PM, Parise C: Comparison of SMART stent placement for arteriovenous graft salvage versus successful graft PTA. J Vasc Interv Radiol 16: 1619-1626, 2005
45. Chan MR, Bedi S, Sanchez RJ, Young HN, Becker YT, Kellerman PS, Yevzlin AS: Stent placement versus angioplasty improves patency of arteriovenous grafts and blood flow of arteriovenous fistulae. Clin J Am Soc Nephrol 3: 699-705, 2008
46. Rotmans JI, Pattynama PM, Verhagen HJ, Hino I, Velema E, Pasterkamp G, Stroes ES: Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: A 4-week follow-up study. Circulation 111: 1537-1542, 2005
47. Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, Berman S, McLennan G, Trimmer C, Ross J, Vesely T: Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med 362: 494-503, 2010
48. Seedial SM, Ghosh S, Saunders RS, Suwanabol PA, Shi X, Liu B, Kent KC: Local drug delivery to prevent restenosis. J Vasc Surg 57: 1403-1414, 2013
49. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D: A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373: 897-910, 2009
50. Barath P, Fishbein MC, Vari S, Forrester JS: Cutting balloon: A novel approach to percutaneous angioplasty. Am J Cardiol 68: 1249-1252, 1991
51. Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC: Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol 19: 877-883, 2008
52. Bhat R, McBride K, Chakraverty S, Vikram R, Severn A: Primary cutting balloon angioplasty for treatment of venous stenoses in native hemodialysis fistulas: Long-term results from three centers. Cardiovasc Intervent Radiol 30: 1166-1170, 2007
53. Vorwerk D, Adam G, Müller-Leisse C, Guenther RW: Hemodialysis fistulas and grafts: Use of cutting balloons to dilate venous stenoses. Radiology 201: 864-867, 1996
54. Guiu B, Loffroy R, Ben Salem D, Cercueil JP, Aho S, Mousson C, Krausé D: Angioplasty of long venous stenoses in hemodialysis access: At last an indication for cutting balloon? J Vasc Interv Radiol 18: 994-1000, 2007
55. Vesely TM, Siegel JB: Use of the peripheral cutting balloon to treat hemodialysis-related stenoses. J Vasc Interv Radiol 16: 1593-1603, 2005
56. Huijbregts HJ, de Borst GJ, Veldhuis WB, Verhagen HJ, Velema E, Pasterkamp G, Moll FL, Blankestijn PJ, Hoefer IE: Cryoplasty of the venous anastomosis for prevention of intimal hyperplasia in a validated porcine arteriovenous graft model. Eur J Vasc Endovasc Surg 39: 620-626, 2010
57. Rifkin BS, Brewster UC, Aruny JE, Perazella MA: Percutaneous balloon cryoplasty: A new therapy for rapidly recurrent anastomotic venous stenoses of hemodialysis grafts? Am J Kidney Dis 45: e27-e32, 2005
58. Hwang SH, Wagner KM, Morisseau C, Liu JY, Dong H, Wecksler AT, Hammock BD: Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase. J Med Chem 54: 3037-3050, 2011
59. El Sharouni SY, Smits HF, Wüst AF, Battermann JJ, Blankestijn PJ: Endovascular brachytherapy in arteriovenous grafts for haemodialysis does not prevent development of stenosis. Radiother Oncol 49: 199-200, 1998
60. van Tongeren RB, Levendag PC, Coen VL, Schmitz PI, Gescher FM, Vernhout RM, Wittens CH, Bruijninckx CM: External beam radiation therapy to prevent anastomotic intimal hyperplasia in prosthetic arteriovenous fistulas: Results of a randomized trial. Radiother Oncol 69: 73-77, 2003
61. Misra S, Bonan R, Pflederer T, Roy-Chaudhury P; BRAVO I Investigators: BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney Int 70: 2006-2013, 2006
62. Luo Z, Akita GY, Date T, Treleaven C, Vincent KA, Woodcock D, Cheng SH, Gregory RJ, Jiang C: Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs. Circulation 111: 1679-1684, 2005
63. Terry CM, Li L, Li H, Zhuplatov I, Blumenthal DK, Kim SE, Owen SC, Kholmovski EG, Fowers KD, Rathi R, Cheung AK: In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis. J Control Release 160: 459-467, 2012
64. Rotmans JI, Stroes ES, Pasterkamp G: Letter regarding article by Luo et al, "Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs." Circulation 112: e153, 2005
65. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94: 1655-1664, 1996
66. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN: Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93: 2178-2187, 1996
67. Tomas JJ, Stark VE, Kim JL, Wolff RA, Hullett DA, Warner TF, Hoch JR: Beta-galactosidase-tagged adventitial myofibroblasts tracked to the neointima in healing rat vein grafts. J Vasc Res 40: 266-275, 2003
68. Kuji T, Masaki T, Goteti K, Li L, Zhuplatov S, Terry CM, Zhu W, Leypoldt JK, Rathi R, Blumenthal DK, Kern SE, Cheung AK: Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis. Kidney Int 69: 2179-2185, 2006
69. Owen SC, Li H, Sanders WG, Cheung AK, Terry CM: Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft. J Control Release 146: 23-30, 2010
70. Sanders WG, Hogrebe PC, Grainger DW, Cheung AK, Terry CM: A biodegradable perivascular wrap for controlled, local and directed drug delivery. J Control Release 161: 81-89, 2012
71. Kelly B, Melhem M, Zhang J, Kasting G, Li J, Krishnamoorthy M, Heffelfinger S, Rudich S, Desai P, Roy-Chaudhury P: Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant 21: 2425-2431, 2006
72. Paulson WD, Kipshidze N, Kipiani K, Beridze N, DeVita MV, Shenoy S, Iyer SS: Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodialysis graft patency: First human experience with a sirolimus-eluting collagen membrane (Coll-R). Nephrol Dial Transplant 27: 1219-1224, 2012
73. Nathan A, Nugent MA, Edelman ER: Tissue engineered perivascular endothelial cell implants regulate vascular injury. Proc Natl Acad Sci U S A 92: 8130-8134, 1995
74. Nugent HM, Rogers C, Edelman ER: Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res 84: 384-391, 1999
75. Nugent HM, Edelman ER: Endothelial implants provide longterm control of vascular repair in a porcine model of arterial injury. J Surg Res 99: 228-234, 2001
76. Nugent HM, Groothuis A, Seifert P, Guerraro JL, Nedelman M, Mohanakumar T, Edelman ER: Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: A safety and efficacy study in the pig. J Vasc Res 39: 524-533, 2002
77. Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH: Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: The V-HEALTH study. J Vasc Surg 50: 1359-1368, 2009
78. Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH: Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg 54: 1383-1389, 2011
79. Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, de Kleijn DP, de Groot FG, Stroes ES, Pasterkamp G: In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 112: 12-18, 2005
80. Rotmans JI, Heyligers JM, Stroes ES, Pasterkamp G: Endothelial progenitor cell-seeded grafts: Rash and risky. Can J Cardiol 22: 1113-1116, 2006
81. Peden EK, Leeser DB, Dixon BS, El-Khatib MT, Roy-Chaudhury P, Lawson JH, Menard MT, Dember LM, Glickman MH, Gustafson PN, Blair AT, Magill M, Franano FN, Burke SK: A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access 14: 143-151, 2013
82. Masuda A, Miyata M, Kihara T, Minagoe S, Tei C: Repeated sauna therapy reduces urinary 8-epi-prostaglandin F(2alpha). Jpn Heart J 45: 297-303, 2004
83. Kipshidze N, Nikolaychik V, Muckerheidi M, Keelan MH, Chekanov V, Maternowski M, Chawla P, Hernandez I, Iyer S, Dangas G, Sahota H, Leon MB, Roubin G, Moses JW: Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury model. Circulation 104: 1850-1855, 2001
84. Lin CC, Liu XM, Peyton K, Wang H, Yang WC, Lin SJ, Durante W: Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol 28: 739-745, 2008
85. Lin CC, Yang WC, Chen MC, Liu WS, Yang CY, Lee PC: Effect of far infrared therapy on arteriovenous fistulamaturation: An open-label randomized controlled trial. Am J Kidney Dis 62: 304-311, 2013
86. Dahl SL, Blum JL, Niklason LE: Bioengineeredvascular grafts:Canwe make them off-the-shelf? Trends Cardiovasc Med 21: 83-89, 2011
87. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, McAllister T: Technology insight: The evolution of tissueengineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 4: 389-395, 2007
88. Peck MK, Dusserre N, Zagalski K, Garrido SA, Wystrychowski W, Glickman MH, Chronos NA, Cierpka L, L'Heureux N, McAllister TN: New biological solutions for hemodialysis access. J Vasc Access 12: 185-192, 2011
89. Tillman BW, Yazdani SK, Neff LP, Corriere MA, Christ GJ, Soker S, Atala A, Geary RL, Yoo JJ: Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg 56: 783-793, 2012
90. Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE: Readily available tissue-engineered vascular grafts. Sci Transl Med 3: 68ra9-192, 2011
91. Surgeons at Duke University Hospital Implant Bioengineered Vein. Available at: http://www.dukehealth.org/health_library/news/surgeons-at-duke-university-hospital-implant-bioengineered-vein. Accessed June 6, 2013.
92. Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M Jr, Miller A, Scher L, Trerotola S, Gregory RT, Rutherford RB, Kent KC: Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 35: 603-610, 2002
93. Murad MH, Swiglo BA, Sidawy AN, Ascher E, Montori VM: Methodology for clinical practice guidelines for themanagement of arteriovenous access. J Vasc Surg 48[Suppl]: 26S-30S, 2008
94. Lee T, Mokrzycki M, Moist L, Maya I, Vazquez M, Lok CE; North American Vascular Access Consortium: Standardized definitions for hemodialysis vascular access. Semin Dial 24: 515-524, 2011
95. Dember LM, Imrey PB, Beck GJ, Cheung AK, Himmelfarb J, Huber TS, Kusek JW, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Vita JA, Greene T, Gassman JJ, Feldman HI; Hemodialysis Fistula Maturation Study Group: Objectives and design of the Hemodialysis Fistula Maturation Study [published online ahead of print August 27, 2013]. Am J Kidney Dis, 10.1053/j.ajkd.2013.06.024
96. Manson RJ, Ebner A, Gallo S, Chemla E, Mantell M, Deaton D, Roy-Chaudhury P: Arteriovenous fistula creation using the Optiflow vascular anastomosis device: A first in man pilot study. Semin Dial 26: 97-99, 2013